Neueste Versuche

EudraCT Number: 2004-000730-37

Sponsor Protocol Number: 42603ATT3002

Start Date: 2005-02-07

Sponsor Name: Janssen-Cilag Medical Affairs EMEA

Full Title: A multicentre, randomised, double-blind, placebo-controlled, parallel group, dose-response phase III A study to evaluate safety and efficacy of Prolonged Release (PR) OROS methylphenidate (18, 36 a...

Medical condition: Attention Deficit Hyperactivity Disorder (ADHD)

Disease:	Version	SOC Term	Classification Code	Term	Level
			10003731

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed) DK (Completed) CZ (Completed) FI (Completed)

Trial results: View results

EudraCT Number: 2004-005138-38

Sponsor Protocol Number: 2602-415

Start Date: 2005-02-07

Sponsor Name: Hvidovre Hospital

Full Title: Antibiotikaprofylakse ved vaginalplastik

Medical condition: Uterine prolapse grade I-II, cystocele and/or rectocele and/or enterocele grade I - IV and/or defects of the perineal body where there is medical indication for vaginal repair, but no indication fo...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-004090-29

Sponsor Protocol Number: AVD100521

Start Date: 2005-02-07

Sponsor Name: GlaxoSmithKline Research & Development Ltd [...] 1. GlaxoSmithKline Research & Development Ltd 2. GlaxoSmithKline R&D

Full Title: A Phase III, 18 Month, Multicenter, Randomized, Double-Blind, Active-Controlled Clinical Trial to Compare Rosiglitazone versus Glipizide on the Progression of Atherosclerosis in Subjects with Type ...

Medical condition: atherosclerosis in Type 2 Diabetes Mellitus patients with cardiovascular disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.1		10003601		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Completed) DE (Completed) LV (Completed) IT (Completed) CZ (Completed) GR (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-003839-31

Sponsor Protocol Number: ELN100226-CD354

Start Date: 2005-02-05

Sponsor Name: Elan Pharma Ltd.

Full Title: A Phase III, Multicenter, Open-Label, Long-Term Study of the Tolerability of Intravenous Natalizumab in Crohn's Disease Subjects Who Have Previously Participated in Natalizumab Crohn's Disease Stud...

Medical condition: Crohn's Disease (CD)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003215-22

Sponsor Protocol Number: vit-001

Start Date: 2005-02-04

Sponsor Name: Antonio Noda Cabrera

Full Title: Ensayo clínico piloto, unicéntrico, aleatorizado, doble ciego, con dos grupos paralelos sobre el efecto del Tacalcitol en pacientes afectos de vitíligo.

Medical condition: vitiligo vulgaris

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.0		10040829		NEC

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-001664-50

Sponsor Protocol Number: DS/04/FTMS/01

Start Date: 2005-02-04

Sponsor Name: ITALFARMACO

Full Title: An open label, phase II multicentre evaluation of the activity and safety of fotemustine administered to patients with recurrent or progressive glioblastoma multiforme.

Medical condition: Recurrent or progressive glioblastoma multiforme after radiotherapy and adjuvant chemiotherapy.

Disease:	Version	SOC Term	Classification Code	Term	Level
			10018337		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004893-96

Sponsor Protocol Number: cat 2; version1.2;

Start Date: 2005-02-04

Sponsor Name: Hammersmith Hospitals NHS trust

Full Title: Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis

Medical condition: Patients with medical diagnosis of Rheumatoid Arthritis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-004077-29

Sponsor Protocol Number: 2004112

Start Date: 2005-02-04

Sponsor Name: Procter & Gamble Pharmaceuticals

Full Title: A Double-blind, Randomized, Multicenter, Active-control, 56-day Study with a 28-day Follow-up to Assess the Efficacy and Safety of RDP58 200 mg/day plus Mesalazine 2.4 g/day and RDP58 600 mg/day pl...

Medical condition: Ulcerative colitis is characterized by acute and chronic inflammatory changes to the mucosa and submucosa of the colon and rectum. Clinical presentations include increased stool frequency, bloody d...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) LT (Completed) SK (Completed) CZ (Completed) GB (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003865-33

Sponsor Protocol Number: CCR100136

Start Date: 2005-02-03

Sponsor Name: GlaxoSmithKline Research & Development Ltd

Full Title: A Phase IIb, 96 week, randomized, open-label, multicenter, parallel group, repeat dose study to evaluate the safety, tolerability, pharmacokinetics and antiviral effect of different doses and regim...

Medical condition: Treatment of HIV-1 infection

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) IT (Prematurely Ended) DE (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2004-004377-28

Sponsor Protocol Number: CFTY720A0124E1

Start Date: 2005-02-03

Sponsor Name: Novartis Pharma AG

Full Title: A two-year extension to a one-year, multicenter, partially blinded, double-dummy, randomized study to evaluate the efficacy and safety of FTY720 combined with reduced-dose or full-dose Neoral and c...

Medical condition: Prophylaxis of kidney allograft rejection in de novo adult renal transplant recipients

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10023439		LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: View results

Neueste Versuche

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen